ONTARIO’S ENERGY FUTURE: GETTING THE SUPPLY MIX RIGHT[>>>]
The Ontario Power Authority is submitting an updated Integrated Power System Plan to help Ontario anticipate and meet its long-term electricity needs. Up to now, planning has been based on a risk-mitigation perspective focused on peak capacity and provincial supply self-sufficiency. In SECOR’s view this is fundamentally expensive and has led to overcapacity. An increasingly relevant question is: “Are there other perspectives which can help reduce costs and safely meet the supply needs for Ontario’s future?”
In the point of view, SECOR examines the fundamental drivers of the current twenty-year projection of Ontario’s energy needs, contrasted against an operational planning perspective.
GENERIC DRUG PRICING AND ACCESS IN CANADA: WHAT ARE THE IMPLICATIONS?
A commissioned discussion paper by SECOR Consulting for The Health Council of Canada [>>>]
By Dr. David Griller, Joshua Lawson and Dusan Lovren from SECOR and Dr. Chaim Bell from Li Ka Shing Knowledge Institute of St. Michael's Hospital, and University of Toronto
Health Council of Canada, June 2010
Unternehmenskontrolle: Nachhaltig akquirieren, (Corporate Control: Finding a balance) [>>>]
By Frank Daufenbach and Ken Smith
Harvard Business Manager Germany, September 2009
Misaligned Incentives and the Economic Crisis [>>>]
By Ken Smith
Business Week, April 2009
How the Board’s Role in Strategy Fulfills a Risk Management Responsibility [>>>]
By Hugh Goldie, Ken Smith and Peter Stephenson
Director, April 2009
Once upon a time [>>>]
By Chu Ba Trung
January 2009
More banks will guarantee growth potential [>>>]
By Han Jung Woo
January 2009
The ‘Short-bolting’ of the Financial System: Dangerous Compensation Schemes and Questions for Directors [>>>]
By Ken Smith
December 2008
This article was reprinted with permission from the December 2008 edition of Director, published by the Institute of Corporate Directors
Take Aim at the Right Targets [>>>]
By Han Jung Woo / Thomas Delahaye
December 2008
Navigating the Acquisition Road to Market Leadership
September 2008
How to Build a Pharmaceutical Industry: Québec’s Story
David Griller, Partner SECOR-Taktik
Daniel Denis, Partner SECOR-Taktik
Montréal attracts almost half of Canada’s multinational pharmaceutical investments and, by most metrics, is a worthy international competitor to any other city renowned for its pharmaceutical industry. David Griller and Daniel Denis explain how Quebec's far-sighted public policies encouraged investment by multinational firms and spawned a thriving biopharmaceutical cluster.
Send me a free hard copy: call Chantal Latour – 514-861-9031
Guide d'affaires Opportunités Vietnam English version coming soon
SECOR Asia, in collaboration with the SECOR-Taktik’s Montreal office, has recently published an extensive Business Opportunity Guide for Vietnam. This thorough document is aimed at Canadian SMEs who wish to improve their understanding of the country and grasp the opportunities provided by this thriving Asian economy. The English version of the study will be available for sale shortly.
For more informations or to order, call Chantal Latour -- 514.866.5789
Pharmaceutical Research and Its Value to Canadians
David Griller, Partner SECOR-Taktik
David Griller explains in a simple and entertaining way how the whole process of developing a new drug works, the trials, tribulations and successes that the industry goes through, and the advantages that research brings to patients and the community. This is a “How It Is Done” book, starting with laboratory research through the particular management of pharmaceutical companies followed by the impact of products on human health. Once you have read this book, you will have a good idea on how the industry works and how research benefits Canadians.
How to Build a Pharmaceutical Industry: Québec’s Story
Guide d'affaires Opportunités Vietnam
Pharmaceutical Research and Its Value to Canadians